insights_auto
Why is INO down 16.21%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.22
arrow_downward
-16.21%(-0.24) 1D
$1.27
arrow_upward
+4.53% (+0.055)bedtimeAfter hours
Closed: Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.12
High
$1.27
Low
$1.07
Mkt. cap
125.63M
Avg. vol.
16.17M
Volume
39.72M
52-wk high
$2.72
52-wk low
$0.56
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
Open
$1.12
High
$1.27
Low
$1.07
Mkt. cap
125.63M
Avg. vol.
16.17M
Volume
39.72M
52-wk high
$2.72
52-wk low
$0.56
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
News stories
From web sources and news partners
Investing.com
·
2 days ago
Why is Inovio Pharmaceuticals stock plunging today?
Investing.com
·
2 days ago
Inovio stock tumbles 25% on $75M share offering
StreetInsider
·
2 days ago
Inovio prices $75 million public offering at $1.05 per share
TradingView
·
2 days ago
Inovio Announces Pricing Of Approximately $75 Million Public Offering At $1.05 Per Share
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com